Volcano Receives Average Rating of “Hold” from Brokerages (NASDAQ:VOLC)
Shares of Volcano (NASDAQ:VOLC) have received a consensus recommendation of “Hold” from the sixteen ratings firms that are presently covering the stock, American Banking and Market News reports. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating on the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $18.36.
Volcano (NASDAQ:VOLC) traded up 0.66% during mid-day trading on Thursday, hitting $12.24. 42,170 shares of the company’s stock traded hands. Volcano has a one year low of $11.54 and a one year high of $24.62. The stock’s 50-day moving average is $14.25 and its 200-day moving average is $17.8. The company’s market cap is $629.9 million.
Volcano (NASDAQ:VOLC) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.06. The company had revenue of $102.60 million for the quarter, compared to the consensus estimate of $103.14 million. During the same quarter in the previous year, the company posted $0.03 earnings per share. The company’s revenue for the quarter was up 1.3% on a year-over-year basis. Analysts expect that Volcano will post $-0.18 EPS for the current fiscal year.
Several analysts have recently commented on the stock. Analysts at Leerink Swann reiterated a “market perform” rating on shares of Volcano in a research note on Wednesday, August 13th. They now have a $15.00 price target on the stock, down previously from $18.00. Separately, analysts at Roth Capital cut their price target on shares of Volcano from $24.00 to $16.00 in a research note on Friday, August 8th. They now have a “buy” rating on the stock.
Volcano Corporation (NASDAQ:VOLC) designs, develops, manufactures and commercializes a range of precision guided therapy tools, including intravascular ultrasound (IVUS), and fractional flow reserve (FFR), products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.